Table 2

Demographic and diagnostic data as well as outcome details of all patients with infective endocarditis after Melody valve implantation

PatientGenderDiagnosisAge (years)Size (mm)FU (months)Duke*BacteriaPrevious valveTreatmentPRPS (mm Hg)Presumed entranceOutcome
1MaleTF72214.1DefiniteHACEKBare stentAB 6 weeks0/464Unprotected dental careGood
2MaleTF172013.4PossibleStreptococcus sanguinisHomograftAB 6 weeks1/430Orthodontics+oral wound+10 mm Hg in 27 months
3MaleRastelli141815.5DefiniteStreptococcus viridansHomograftAB 6 weeks0/442Orthodontics+oral wound+10 mm Hg in 11 months
4MaleTrunc142044.4DefiniteHACEKHomograftAB 6 weeks0/462Unprotected dental careMelody in 10 months
5MaleTrunc152216.4PossibleCorynebacterium pseudodiphtheriticumHomograftAB 6 weeks1/422Cryptogenic+11 mm Hg in 1 year
6MaleRastelli92027.6DefiniteStreptococcus viridansHomograftAB 6 weeks0/4<5Unprotected dental care+10 mm Hg in 9 months
7MaleTF172215.5DefiniteHACEKHomograftSurgery at D251/422Dematophytosis complexExplant at D25
8MaleTF122237.7DefiniteStaphylococcus aureusBare stentSurgery at D110/430Personal hygiene+nail bitingExplant at D11
  • *Modified Duke criteria.9

  • AB, antibiotics; FU, follow-up; HACEK, Haemophilus Aggregatibacter Cardiobacterium Eikenella corrodens Kingella; PR, pulmonary valve regurgitation (0–4/4); PS, pulmonary stenosis; TF, Tetralogy of Fallot.